BioSpace News Archive

Business

Catalent, Inc. Reports First Quarter Fiscal 2022 Results

Catalent, Inc. today announced financial results for the first quarter of fiscal 2022, which ended September 30, 2021.

November 2, 2021
·
24 min read
Business

Pieris Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Company To Host an Investor Conference Call on Tuesday, November 2, 2021 at 8:00 AM EDT

November 2, 2021
·
11 min read
Drug Development

Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data from BT7480 Program in the Journal for ImmunoTherapy of Cancer

Bicycle Therapeutics plc today announced that an article highlighting preclinical data from BT7480, a tumor-targeted immune cell agonist (TICA) targeting Nectin-4 and agonizing CD137 (4-1BB), was published in the Journal for ImmunoTherapy of Cancer.

November 2, 2021
·
5 min read
Innovative Embolic Device Shows Promise for Interventional Oncology Drug Delivery

Fluidx Medical Technology announced that a next-generation, doxorubicin-loaded GPX Embolic Device was featured at the recent Symposium on Clinical Interventional Oncology (CIO) Conference

November 2, 2021
·
2 min read
Business

Acerus to Report Q3-2021 Financial Results and Host Investor Call

Acerus Pharmaceuticals Corporation will announce its third quarter 2021 financial and operating results on Tuesday, November 9, 2021 before the market opens.

November 2, 2021
·
1 min read
Business

Omnicell Announces Financial Results for Third Quarter 2021

Omnicell, Inc. today announced results for its third quarter ended September 30, 2021.

November 2, 2021
·
33 min read
BioMidwest

Inspire Medical Systems, Inc. to Present at the Stifel 2021 Virtual Healthcare Conference

Inspire Medical Systems, Inc. announced today that its management team will present at the Stifel 2021 Virtual Healthcare Conference on Tuesday, November 16, 2021.

November 2, 2021
·
1 min read
Biotech Beach

Histogen and Amerimmune Announce the Presentation of Emricasan Data in COVID-19 at the American College of Allergy, Asthma, and Immunology Conference

Histogen Inc. today announced that Amerimmune’s CEO, Oral Alpan, MD, will present updated findings from the emricasan Phase 1 study in mild symptomatic COVID-19 patients at the American College of Allergy, Asthma, and Immunology Conference in New Orleans on November 6, 2021.

November 2, 2021
·
7 min read
Pharm Country

Intra-Cellular Therapies to Host Third Quarter 2021 Financial Results Conference Call and Webcast

Intra-Cellular Therapies, Inc. today announced that it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Tuesday, November 9, 2021, to provide a corporate update and discuss details of the Company’s financial results for the quarter ended September 30, 2021.

November 2, 2021
·
1 min read
Pharm Country

Beyond Air® to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

Beyond Air, Inc. today announced that Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference being held from November 30 – December 2, 2021.

November 2, 2021
·
4 min read